Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mar 1, 2022
The Source Spring 2022
Magazine of the plasma protein therapeutics industry - Spring 2022
All
The Source Magazine
https://drive.google.com/file/d/1YYNlKYft6GGiSCcPDRt-OaopCQ9e8xOR/view?usp=sharing
Mar 1, 2022
The Source Spring 2022
Magazine of the plasma protein therapeutics industry - Spring 2022
All
The Source Magazine
https://drive.google.com/file/d/1YYNlKYft6GGiSCcPDRt-OaopCQ9e8xOR/view?usp=sharing
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
No results found